Literature DB >> 23120119

Pre-cancerous changes in the nasal mucosa of atrophic rhinitis: A preliminary report.

V Raveenthiran1.   

Abstract

Metaplasia is a known predisposing factor to malignancy. As squamous metaplasia is a regular feature of atrophic rhinitis, its relationship with cancer is examined in this cross-sectional study. Random punch biopsies of nasal mucosa obtained from 14 patients (6 male and 8 female) suffering from primary atrophic rhinins were studied. Squamous metaplasia was noted in 64%. Epithelial dysplasia and in-situ malignant transformation were noted in one patient each. This preliminary report suggests that the association of atrophic rhimitis and pre-cancerous lesions appear to be more than coincidental and it deserves further studies.

Entities:  

Keywords:  Atrophic Rhinitis—complication; Cancer; Metaplasia—Dysplasia; Neoplasia; Nose—Pathology; Ozena

Year:  2005        PMID: 23120119      PMCID: PMC3451551          DOI: 10.1007/BF02907622

Source DB:  PubMed          Journal:  Indian J Otolaryngol Head Neck Surg        ISSN: 2231-3796


  4 in total

1.  A study of the histology and exfoliative cytology of atrophic rhinitis.

Authors:  S N Sinha; K C Samuel; T M Juneja; D P Mittal
Journal:  J Laryngol Otol       Date:  1975-10       Impact factor: 1.469

Review 2.  Atrophic rhinitis.

Authors:  M A Shehata
Journal:  Am J Otolaryngol       Date:  1996 Mar-Apr       Impact factor: 1.808

3.  Carcinogenetic action of the implant of acrylic tabs in ozena.

Authors:  F Rodriguez-Adrados; J Estvill
Journal:  Rhinology       Date:  1987-09       Impact factor: 3.681

4.  Desquamation and squamotransformation of rhinomucosa as a prodromal sign of atrophic rhinitis.

Authors:  H S Chen
Journal:  ORL J Otorhinolaryngol Relat Spec       Date:  1984       Impact factor: 1.538

  4 in total
  1 in total

1.  Study of histopathological changes in primary atrophic rhinitis.

Authors:  Sampan S Bist; Manisha Bisht; Jagdish P Purohit; Ratna Saxena
Journal:  ISRN Otolaryngol       Date:  2011-12-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.